Abstract
Background: Valve-in-Valve (VIV) transcatheter aortic valve replacement (TAVR) is a potential solution for malfunctioning surgical aortic valve prostheses, though limited data exist for its use in Perceval valves. Methods: searches were performed on PubMed and Scopus up to 31 July 2023, focusing on case reports and series addressing VIV replacement for degenerated Perceval bioprostheses. Results: Our analysis included 57 patients from 27 case reports and 6 case series. Most patients (68.4%) were women, with a mean age of 76 ± 4.4 years and a mean STS score of 6.1 ± 4.3%. Follow-up averaged 9.8 ± 8.9 months, the mean gradient reduction was 15 ± 5.9 mmHg at discharge and 13 ± 4.2 mmHg at follow-up. Complications occurred in 15.7% of patients, including atrioventricular block III in four patients (7%), major bleeding or vascular complications in two patients (3.5%), an annular rupture in two patients (3.5%), and mortality in two patients (3.5%). No coronary obstruction was reported. Balloon-expanding valves were used in 61.4% of patients, predominantly the Sapien model. In the self-expanding group (38.6%), no valve migration occurred, with a permanent pacemaker implantation rate of 9%, compared to 5.7% for balloon-expanding valves. Conclusions: VIV-TAVR using both balloon-expanding and self-expanding technologies is feasible after the implantation of Perceval valves; however, it should be performed by experienced operators with experience both in TAVR and VIV procedures.
Share and Cite
MDPI and ACS Style
Owais, T.; Bisht, O.; El Din Moawad, M.H.; El-Garhy, M.; Stock, S.; Girdauskas, E.; Kuntze, T.; Amer, M.; Lauten, P.
Outcomes of Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) after Surgical Aortic Valve Replacement with Sutureless Surgical Aortic Valve Prostheses Perceval™: A Systematic Review of Published Cases. J. Clin. Med. 2024, 13, 5164.
https://doi.org/10.3390/jcm13175164
AMA Style
Owais T, Bisht O, El Din Moawad MH, El-Garhy M, Stock S, Girdauskas E, Kuntze T, Amer M, Lauten P.
Outcomes of Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) after Surgical Aortic Valve Replacement with Sutureless Surgical Aortic Valve Prostheses Perceval™: A Systematic Review of Published Cases. Journal of Clinical Medicine. 2024; 13(17):5164.
https://doi.org/10.3390/jcm13175164
Chicago/Turabian Style
Owais, Tamer, Osama Bisht, Mostafa Hossam El Din Moawad, Mohammad El-Garhy, Sina Stock, Evaldas Girdauskas, Thomas Kuntze, Mohamed Amer, and Philipp Lauten.
2024. "Outcomes of Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) after Surgical Aortic Valve Replacement with Sutureless Surgical Aortic Valve Prostheses Perceval™: A Systematic Review of Published Cases" Journal of Clinical Medicine 13, no. 17: 5164.
https://doi.org/10.3390/jcm13175164
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.